Prefilled syringes for immunoglobulin G (IgG) replacement therapy: clinical experience from other disease settings

References

• Picard, C., Bobby GH, Al-Herz W, et al. International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38(1):96–128.
   PubMed Web of Science ®Google Scholar
• Albin S, Cunningham-Rundles C. An update on the use of immunoglobulin for the treatment of immunodeficiency disorders. Immunotherapy. 2014;6(10):1113–1126.
   PubMed Web of Science ®Google Scholar
• Champi C. Primary immunodeficiency disorders in children: prompt diagnosis can lead to lifesaving treatment. J Pediatr Health Care. 2002;16(1):16–21.
   PubMedGoogle Scholar
• Wood P, UK Primary Immunodeficiency Network. Primary antibody deficiencies: recognition, clinical diagnosis and referral of patients. Clin Med (Lond). 2009;9(6):595–599.
   PubMed Web of Science ®Google Scholar
• Perez EE, Orange JS, Bonilla F, et al. Update on the use of immunoglobulin in human disease: A review of evidence. J Allergy Clin Immunol. 2017;139(3s):S1–S46.
   PubMed Web of Science ®Google Scholar
• Koch F. [1st experiences with gamma-venin, an intravenously injectable gamma globulin preparation, in pediatrics]. Dtsch Med Wochenschr. 1963;88:282–285.
   PubMedGoogle Scholar
• Jolles S, Orange JS, Gardulf A, et al. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015;179(2):146–160.
   PubMed Web of Science ®Google Scholar
• Chapel H, Gardulf A. Subcutaneous immunoglobulin replacement therapy: the European experience. Curr Opin Allergy Clin Immunol. 2013;13(6):623–629.
   PubMed Web of Science ®Google Scholar
• Croom KF, McCormack PL. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders. BioDrugs. 2008;22(2):121–136.
   PubMed Web of Science ®Google Scholar
• Frampton JE. Efmoroctocog Alfa: a review in haemophilia A. Drugs. 2016;76(13):1281–1291.
   PubMed Web of Science ®Google Scholar
• Shafer, F., Charnigo RJ, Plotka A, et al. Assessment of relative bioavailability of two presentations of moroctocog alfa (AF-CC) in subjects with moderately severe or severe hemophilia A. Clin Pharmacol Drug Dev. 2015;4(3):237–241.
   PubMed Web of Science ®Google Scholar
• Ingle RG, Agarwal AS. Pre-filled syringe - a ready-to-use drug delivery system: a review. Expert Opin Drug Deliv. 2014;11(9):1391–1399.
   PubMed Web of Science ®Google Scholar
• Jezek J, Darton NJ, Derham BK, et al. Biopharmaceutical formulations for pre-filled delivery devices. Expert Opin Drug Deliv. 2013;10(6):811–828.
   PubMed Web of Science ®Google Scholar
• Callis Duffin, K., Bagel J, Bukhalo M, et al. Phase 3, open-label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate-to-severe plaque psoriasis (UNCOVER-A). J Eur Acad Dermatol Venereol. 2017;31(1):107–113.
   PubMed Web of Science ®Google Scholar
• Chioato A, Noseda E, Colin L, et al. Bioequivalence of canakinumab liquid pre-filled syringe and reconstituted lyophilized formulations following 150 mg subcutaneous administration: a randomized study in healthy subjects. Clin Drug Investig. 2013;33(11):801–808.
   PubMed Web of Science ®Google Scholar
• Struemper H, Murtaugh T, Gilbert J, et al. Relative bioavailability of a single dose of belimumab administered subcutaneously by prefilled syringe or autoinjector in healthy subjects. Clin Pharmacol Drug Dev. 2016;5(3):208–215.
   PubMed Web of Science ®Google Scholar
• Yang BB, Morrow PK, Wu X, et al. Comparison of pharmacokinetics and safety of pegfilgrastim administered by two delivery methods: on-body injector and manual injection with a prefilled syringe. Cancer Chemother Pharmacol. 2015;75(6):1199–1206.
   PubMed Web of Science ®Google Scholar
• Zhuang Y, de Vries DE, Marciniak SJ, et al. Absolute bioavailability and pharmacokinetic comparability of sirukumab following subcutaneous administration by a prefilled syringe or an autoinjector. Clin Pharmacol Drug Dev. 2017;6(6):570–576.
   PubMed Web of Science ®Google Scholar
• Dentinger PJ, Swenson CF. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes. Ann Pharmacother. 2009;43(3):485–489.
   PubMed Web of Science ®Google Scholar
• Garg A, Chan D, Ambados F, et al. Penicillin stability in prefilled syringes for the purpose of skin testing for drug allergy. J Allergy Clin Immunol Pract. 2015;3(4):599–601.
   PubMed Web of Science ®Google Scholar
• Kerddonfak, S, Manuyakorn W, Kamchaisatian W, et al. The stability and sterility of epinephrine prefilled syringe. Asian Pac J Allergy Immunol. 2010;28(1):53–57.
   PubMed Web of Science ®Google Scholar
• Khalili H, Sharma G, Froome A, et al. Storage stability of bevacizumab in polycarbonate and polypropylene syringes. Eye (Lond). 2015;29(6):820–827.
   PubMed Web of Science ®Google Scholar
• Lull ME, Piacentino JJ, Traina AN. Stability of U-500 regular insulin in prefilled syringes. J Am Pharm Assoc. 2003;53(3):304–306.
   Google Scholar
• Naughton CA, Duppong LM, Forbes KD, et al. Stability of multidose, preserved formulation epoetin alfa in syringes for three and six weeks. Am J Health Syst Pharm. 2003;60(5):464–468.
   PubMed Web of Science ®Google Scholar
• Palmer JM, Amoaku WM, Kamali F. Quality of bevacizumab compounded for intravitreal administration. Eye (Lond). 2013;27(9):1090–1097.
   PubMed Web of Science ®Google Scholar
• Rigge DC, Jones MF. Shelf lives of aseptically prepared medicines–stability of netilmicin injection in polypropylene syringes. J Pharm Biomed Anal. 2004;35(5):1251–1256.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wei M, Sun G, et al. Real-time stability of a hepatitis E vaccine (Hecolin(R)) demonstrated with potency assays and multifaceted physicochemical methods. Vaccine. 2016;34(48):5871–5877.
   PubMed Web of Science ®Google Scholar
• Blauvelt A, Prinz JC, Gottlieb AB, et al. Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE). Br J Dermatol. 2015;172(2):484–493.
   PubMed Web of Science ®Google Scholar
• Braun, J., Kastner P, Flaxenberg P, et al. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial. Arthritis Rheum.. 2008;58(1):73–81.
   PubMed Web of Science ®Google Scholar
• Caron P, Beckers A, Cullen DR, et al. Efficacy of the new long-acting formulation of lanreotide (lanreotide autogel) in the management of acromegaly. J Clin Endocrinol Metab. 2002;87(1):99–104.
   PubMed Web of Science ®Google Scholar
• Johanson V, Wilson B, Abrahamsson A, et al. Randomized crossover study in patients with neuroendocrine tumors to assess patient preference for lanreotide autogel((R)) given by either self/partner or a health care professional. Patient Prefer Adherence. 2012;6:703–710.
   PubMedGoogle Scholar
• Spinowitz B, Coyne DW, Lok CE, et al. C.E.R.A. maintains stable control of hemoglobin in patients with chronic kidney disease on dialysis when administered once every two weeks. Am J Nephrol. 2008;28(2):280–289.
   PubMed Web of Science ®Google Scholar
• Stohl W, Schwarting A, Okada M, et al. Efficacy and safety of subcutaneous belimumab in systemic lupus erythematosus: a fifty-two-week randomized, double-blind, placebo-controlled study. Arthritis Rheumatol. 2017;69(5):1016–1027.
   PubMed Web of Science ®Google Scholar
• Phillips, JT, Rice G, Frohman E, et al. A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of avonex in patients with multiple sclerosis. Clin Ther. 2004;26(4):511–521.
   PubMed Web of Science ®Google Scholar
• Somerville L, Bardelas J, Viegas A, et al. Immunogenicity and safety of omalizumab in pre-filled syringes in patients with allergic (IgE-mediated) asthma. Curr Med Res Opin. 2014;30(1):59–66.
   PubMed Web of Science ®Google Scholar
• Yang Y, Rivera AJ, Fortier CR, et al. A human factors engineering study of the medication delivery process during an anesthetic: self-filled syringes versus prefilled syringes. Anesthesiology. 2016;124(4):795–803.
   PubMed Web of Science ®Google Scholar
• Adapa RM, Mani V, Murray LJ, et al. Errors during the preparation of drug infusions: a randomized controlled trial. Br J Anaesth. 2012;109(5):729–734.
   PubMed Web of Science ®Google Scholar
• Barber ND, Hoffmeyer UK. Comparison of the cost-effectiveness of administering heparin subcutaneously or intravenously for the treatment of deep vein thrombosis. Ann R Coll Surg Engl. 1993;75(6):430–433.
   PubMed Web of Science ®Google Scholar
• Elsey L. Service evaluation of a cystic fibrosis home intravenous antibiotic service provided by a NHS foundation trust. Arch Dis Child. 2016;101(9):e2.
   PubMedGoogle Scholar
• Helm C, Gillett M. Adrenaline in cardiac arrest: prefilled syringes are faster. Emerg Med Australas. 2015;27(4):312–316.
   PubMed Web of Science ®Google Scholar
• Pereira CC, Bishai D. Vaccine presentation in the USA: economics of prefilled syringes versus multidose vials for influenza vaccination. Expert Rev Vaccines. 2010;9(11):1343–1349.
   PubMed Web of Science ®Google Scholar
• Scheifele, DW, et al. Evaluation of ready-to-use and multi-dose influenza vaccine formats in large clinic settings. Can J Public Health. 2000;91(5):329–332.
   PubMed Web of Science ®Google Scholar
• Souied E, Nghiem-Buffet S, Leteneux C, et al. Ranibizumab prefilled syringes: benefits of reduced syringe preparation times and less complex preparation procedures. Eur J Ophthalmol. 2015;25(6):529–534.
   PubMed Web of Science ®Google Scholar
• Subhi Y, Kjer B, Munch IC. Prefilled syringes for intravitreal injection reduce preparation time. Dan Med J. 2016;63(4):A5214.
   PubMed Web of Science ®Google Scholar
• Moreira ME, Hernandez C, Stevens AD, et al. Color-coded prefilled medication syringes decrease time to delivery and dosing error in simulated emergency department pediatric resuscitations. Ann Emerg Med. 2015;66(2):97–106.e3.
   PubMed Web of Science ®Google Scholar
• Stevens AD, Hernandez C, Jones S, et al. Color-coded prefilled medication syringes decrease time to delivery and dosing errors in simulated prehospital pediatric resuscitations: A randomized crossover trial. Resuscitation. 2015;96:85–91.
   PubMed Web of Science ®Google Scholar
• Makwana, S, Basu B, Makasana Y, et al. Prefilled syringes: an innovation in parenteral packaging. Int J Pharm Investig. 2011;1(4):200–206.
   PubMedGoogle Scholar
• Prentiss AS, Cockerel A, Butler E. Nurse perceptions and safety practices of the carpuject cartridge system. J Nurs Care Qual. 2016;31(4):350–356.
   PubMed Web of Science ®Google Scholar
• Sacha G, Rogers JA, Miller RL. Pre-filled syringes: a review of the history, manufacturing and challenges. Pharm Dev Technol. 2015;20(1):1–11.
   PubMed Web of Science ®Google Scholar
• Cimino E, Linari S, Malerba M, et al. Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries. Patient Prefer Adherence. 2014;8:1713–1720.
   PubMed Web of Science ®Google Scholar
• Gottlieb, AB, Blauvelt A, Prinz JC, et al. Secukinumab self-administration by prefilled syringe maintains reduction of plaque psoriasis severity over 52 weeks: results of the feature trial. J Drugs Dermatol. 2016;15(10):1226–1234.
   PubMed Web of Science ®Google Scholar
• Plevin S, Sadur C. Use of a prefilled insulin syringe (Novolin prefilled) by patients with diabetes. Clin Ther. 1993;15(2):423–431.
   PubMed Web of Science ®Google Scholar
• Roth EM, Bujas-Bobanovic M, Louie MJ, et al. Patient and physician perspectives on mode of administration of the PCSK9 monoclonal antibody alirocumab, an injectable medication to lower LDL-C levels. Clin Ther. 2015;37(9):1945–1954.e6.
   PubMed Web of Science ®Google Scholar
• Seidl T, Trouillier HH. [Are 55 cents always better value than 90 cents for venous thromboembolism prophylaxis? Comparison of three low-molecular-weight heparins with regard to economics and guideline compliance]. Z Orthop Unfall. 2013;151(5):520–524.
   PubMed Web of Science ®Google Scholar
• Striesow F, Brandt A. Preference, satisfaction and usability of subcutaneously administered methotrexate for rheumatoid arthritis or psoriatic arthritis: results of a postmarketing surveillance study with a high-concentration formulation. Ther Adv Musculoskelet Dis. 2012;4(1):3–9.
   PubMedGoogle Scholar
• Webster, CS, Merry AF, Gander PH, et al. A prospective, randomised clinical evaluation of a new safety-orientated injectable drug administration system in comparison with conventional methods. Anaesthesia. 2004;59(1):80–87.
   PubMed Web of Science ®Google Scholar
• Armoiry X, Carry PY, Lehot JJ, et al. Estimated economic impact of pre-filled ephedrine syringes in the operating room. Acta Anaesthesiol Scand. 2016;60(7):917–924.
   PubMed Web of Science ®Google Scholar
• Bellefleur, JP, Milhaud Y, Beconcini G, et al. [Use of ephedrine prefilled syringes reduces anesthesia costs]. Ann Fr Anesth Reanim. 2009;28(3):211–214.
   PubMedGoogle Scholar
• Benhamou D, Piriou V, De Vaumas C, et al. Ready-to-use pre-filled syringes of atropine for anaesthesia care in French hospitals - a budget impact analysis. Anaesth Crit Care Pain Med. 2017;36(2):115–121.
   PubMed Web of Science ®Google Scholar
• Cregut-Corbaton, J, Malbranche C, Guignard MH, et al. [Economic impact of strategies using ephedrine prefilled syringes]. Ann Fr Anesth Reanim. 2013;32(11):760–765.
   PubMedGoogle Scholar
• Murdoch H, Jordan L, Tuckey J. Pre-filled thiopental syringes reduce cost and wastage whilst improving safety. Int J Obstet Anesth. 2012;21(4):384–385.
   PubMed Web of Science ®Google Scholar
• Vipond A, de Mello W. Drugs used in anaesthetic emergencies: current practice and a cost analysis of prefilled syringes. Anaesthesia. 2000;55(3):303–304.
   PubMed Web of Science ®Google Scholar
• Wazny, LD, Raymond CB, Do MK, et al. Reduced drug costs from switching hemodialysis patients from epoetin alfa in multidose vials to pre-filled syringes. Cannt J. 2009;19(3):39–41.
   PubMedGoogle Scholar
• Cuddihy RM, Borgman SK. Considerations for diabetes: treatment with insulin pen devices. Am J Ther. 2013;20(6):694–702.
   PubMed Web of Science ®Google Scholar
• McCoy EK, Wright BM. A review of insulin pen devices. Postgrad Med. 2010;122(3):81–88.
   PubMed Web of Science ®Google Scholar
• Guerlain S, Hugine A, Wang L. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference. Ann Allergy Asthma Immunol. 2010;104(2):172–177.
   PubMed Web of Science ®Google Scholar
• Visiongain. Prefilled syringe: world market outlook to 2025. London, UK: Visiongain; 2010.
   Google Scholar
• Kivitz A, Cohen S, Dowd JE, et al. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial. Clin Ther. 2006;28(10):1619–1629.
   PubMed Web of Science ®Google Scholar
• van Dulmen S, Sluijs E, van Dijk L, et al. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007;7:55.
   PubMed Web of Science ®Google Scholar
• Devine EC. Meta-analysis of the effects of psychoeducational care in adults with asthma. Res Nurs Health. 1996;19(5):367–376.
   PubMed Web of Science ®Google Scholar
• Ignaut DA, Schwartz SL, Sarwat S, et al. Comparative device assessments: humalog KwikPen compared with vial and syringe and FlexPen. Diabetes Educ. 2009;35(5):789–798.
   PubMed Web of Science ®Google Scholar
• Lajara R, Guerrero G, Thurman J. Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe. Expert Opin Drug Deliv. 2012;9(10):1181–1196.
   PubMed Web of Science ®Google Scholar
• Shogbon AO, Ngo D, Jacob B, et al. Nurses’ perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting. Diabetes Technol Ther. 2014;16(11):742–746.
   PubMed Web of Science ®Google Scholar
• CSL Behring. Data on file. 2018 [cited 2018 Oct 18]. Available from: https://www.ema.europa.eu/documents/product-information/hizentra-epar-product-information_en.pdf.
   Google Scholar